Digene/Kaiser
This article was originally published in The Gray Sheet
Executive Summary
Digene enters into an agreement in which Kaiser Permanente will utilize the Digene Hybrid Capture II HPV test as part of its cervical cancer screening program. Digene's approved test is used as an adjunct to the Pap smear for cervical cancer screening and detection of the human papilloma virius (HPV), the primary cause of cervical cancer